DAWN — DAY ONE BIOPHARMACEUTICALS I
Public company
Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About DAY ONE BIOPHARMACEUTICALS I (DAWN)
DAY ONE BIOPHARMACEUTICALS I (DAWN) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $41M. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Tracked investors reporting DAWN
- Izzy EnglanderMar 31, 2026Millennium ManagementShares1.9MValue$41.3M% Portfolio0.02%
- George SorosMar 31, 2026Soros Fund ManagementShares1.5MValue$33M% Portfolio0.36%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares418.7KValue$9M% Portfolio0.00%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares156.2KValue$1.5M% Portfolio0.00%
Recent activity
- New$1.5MFeb 17, 2026
- New$33MMay 15, 2026
Frequently asked questions
- How many institutional investors hold DAWN?
- 4 tracked institutional investors disclosed a position in DAWN (DAY ONE BIOPHARMACEUTICALS I) in their most recent 13F filing.
- Who is the largest institutional holder of DAWN?
- Izzy Englander, Millennium Management, holds the largest disclosed position in DAWN, valued at $41M.
- Did institutional ownership of DAWN increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited DAWN.
- Where does this DAWN ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.